Jeffrey A Rose

US Patent:

6521776, Feb 18, 2003

Filed:

Jul 30, 2001

Appl. No.:

09/919049

Inventors:

Lynn D. Hawkins - Concord MA
Sally T. Ishizaka - Weston MA
Jeffrey Rose - Chelmsford MA
Hu Yang - North Andover MA

Assignee:

Eisai Company, Limited - Tokyo

International Classification:

C07F 909

US Classification:

558159, 4241841, 4242781

Abstract:

The present invention provides novel compounds that function as immunological adjuvants when co-administered with antigens, including, antigens used as vaccines for any disease or condition amenable to vaccination. The invention also provides adjuvant formulations comprising the novel compounds of the invention and methods for immunizing humans and non-human animals.

US Patent:

6551600, Apr 22, 2003

Filed:

Jul 31, 2001

Appl. No.:

09/918849

Inventors:

Lynn D. Hawkins - Concord MA
Sally T. Ishizaka - Weston MA
Michael Lewis - Andover MA
Pamela McGuiness - Methuen MA
Jeffrey Rose - Chelmsford MA

Assignee:

Eisai Co., Ltd. - Tokyo

International Classification:

A61K 4500

US Classification:

4242781, 558166, 558172

Abstract:

The present invention is directed to novel compounds that function as immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases, to novel adjuvant formulations which include at least one of the adjuvant compounds of the invention, to novel immunostimulatory compositions which comprise an antigen and at least one of the adjuvant compounds of the invention, and to methods for the immunization of an animal by co-administration of a compound of the invention with an antigen against which the animal is to be immunized.

US Patent:

6835721, Dec 28, 2004

Filed:

Jul 31, 2002

Appl. No.:

10/208936

Inventors:

Lynn D. Hawkins - Concord MA
Sally T. Ishizaka - Weston MA
Michael Lewis - Andover MA
Pamela McGuinness - Methuen MA
Jeffrey Rose - Chelmsford MA

Assignee:

Eisai Co., Ltd. - Tokyo

International Classification:

A61K 3166

US Classification:

514120, 4242781, 558169, 558166, 558172

Abstract:

The present invention is directed to novel compounds that function as immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases, to novel adjuvant formulations which include at least one of the adjuvant compounds of the invention, to novel immunostimulatory compositions which comprise an antigen and at least one of the adjuvant compounds of the invention, and to methods for the immunization of an animal by co-administration of a compound of the invention with an antigen against which the animal is to be immunized.

US Patent:

7560584, Jul 14, 2009

Filed:

Dec 28, 2004

Appl. No.:

11/024328

Inventors:

Lynn D. Hawkins - Concord MA, US
Sally T. Ishizaka - Weston MA, US
Michael Lewis - Andover MA, US
Pamela McGuinness - Methuen MA, US
Jeffrey Rose - Chelmsford MA, US

Assignee:

Eisai R&D Management Co., Ltd. - Bunkyo-Ku, Tokyo

International Classification:

C07F 9/02

US Classification:

558166, 558169, 558170

Abstract:

The present invention is directed to novel compounds that function as immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases, to novel adjuvant formulations which include at least one of the adjuvant compounds of the invention, to novel immunostimulatory compositions which comprise an antigen and at least one of the adjuvant compounds of the invention, and to methods for the immunization of an animal by co-administration of a compound of the invention with an antigen against which the animal is to be immunized.

US Patent:

8384371, Feb 26, 2013

Filed:

Mar 9, 2010

Appl. No.:

12/720617

Inventors:

Jeffrey David Rose - San Jose CA, US

Assignee:

Rosendin Electric, Inc. - San Jose CA

International Classification:

H01F 30/12

US Classification:

323361, 336 5

Abstract:

A method, apparatus, and system in which a neutral deriving transformer incorporates a zig-zag transformer configuration is provided. A zig-zag transformer provides an electrical load with a neutral wire. The zig-zag transformer may be electrically connected downstream of a main AC voltage step-down transformer. Additionally, three phase AC voltage lines can be routed to the zig-zag transformer such that the zig-zag transformer comprises a neutral deriving transformer that electrically connects to a ground conductor. The neutral deriving transformer might not be electrically connected to a neutral conductor of the main voltage step-down transformer. The zig-zag transformer can phase shift each winding by approximately 120 degrees and may derive a neutral for at least one single phase load connected to the zig-zag transformer and one of the three phase AC lines in order to provide a common neutral point that takes the place of a neutral cable that connects back to the main AC voltage step-down transformer.

US Patent:

20100302744, Dec 2, 2010

Filed:

Aug 28, 2009

Appl. No.:

12/549963

Inventors:

Matthew John Englert - San Jose CA, US
Jeffrey David Rose - San Jose CA, US
John Manual Loera - San Jose CA, US

Assignee:

ROSENDIN ELECTRIC, INC. - San Jose CA

International Classification:

H05K 5/04
H05K 13/00

US Classification:

361730, 295921

Abstract:

A method, apparatus, and system are described for a pre-wired and pre-engineered integrated platform for power supply and distribution that is pre-assembled, scalable, and modular. The skeletal framework of the integrated platform acts as an equipment support structure as well as a cable routing support system. A set of cables having wiring is routed along the skeletal framework of the integrated platform and goes to two or more cabinet enclosures mounted onto the skeletal framework. The skeletal framework acts as a National Electric Code approved raceway system to support and route the set of cables to the electrical equipment in the mounted cabinet enclosures. The integrated platform supports the weight of the one or more cabinet enclosures mounted onto the skeletal framework.

US Patent:

62909738, Sep 18, 2001

Filed:

Feb 1, 2000

Appl. No.:

9/496152

Inventors:

Lynn D. Hawkins - Concord MA
Sally T. Ishizaka - Weston MA
Michael Lewis - Andover MA
Pamela McGuiness - Metheun MA
Anneliese Nault - North Billerica MA
Jeffrey Rose - Chelmsford MA
Daniel P. Rossignol - Mahwah NJ

Assignee:

Eisai Co., Ltd. - Tokyo

International Classification:

A61K 4500
A61K 39295
A61K 3900
C07C26100

US Classification:

4242781

Abstract:

The present invention is directed to novel compounds that function as immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases, to novel adjuvant formulations which include at least one of the adjuvant compounds of the invention, to novel immunostimulatory compositions which comprise an antigen and at least one of the adjuvant compounds of the invention, and to methods for the immunization of an animal by co-administration of a compound of the invention with an antigen against which the animal is to be immunized.